Dietary Supplements for the Treatment of Angelman Syndrome
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
Angelman syndrome (AS) is a complex genetic disorder that affects the nervous system. The
purpose of this study is to determine the effectiveness of certain dietary supplements in
treating the symptoms of AS.
Phase:
N/A
Details
Lead Sponsor:
University of California, San Diego
Collaborators:
Baylor College of Medicine Boston Children's Hospital Boston Children’s Hospital Greenwood Genetic Center Rady Children's Hospital, San Diego Rare Diseases Clinical Research Network
Treatments:
Betaine Hydroxocobalamin Vitamin B 12 Vitamin B Complex Vitamins